【摘要】 与跨国公司相比,国内企业存在着研发水平不足、规模实力较小等问题。对于这些问题的解决,医药各子行业中的企业在总体战略上有着各自的选择方向,如:原料药企业的战略选择是通过购并等扩大规模,取得规模优势,以及加速产品仿制和开发;化学制剂药企业是模仿性创新;中药企业是在国内市场塑造知名企业品牌或者产品品牌,在国际市场推动中药规范化;生物制药企业是购买专利和加大研发投入。更多还原

【Abstract】 Compared to the international pharmaceutical enterprises,domestic companies are smaller in the level of research and development.For these problems,domestic companies in different pharmaceutical industries have different choice in their strategy.Active pharmaceutical ingredients companies should get scale advantage through purchasing,and accelerate drag copy and development.Chemical agent companies should develop imitated innovation.Chinese traditional medicine companies should develop company brand or product brand in domestic market,and promote standardization of Chinese traditional medicine in oversea market.Biologic companies should purchase patents and increase investment of research and development.更多还原